康德莱收盘下跌3.75%，滚动市盈率18.22倍，总市值39.27亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Kangdelai, a company in the medical device industry, which is currently facing a decline in stock price and revenue [1][2] - As of August 14, Kangdelai's stock closed at 8.99 yuan, down 3.75%, with a rolling PE ratio of 18.22 times and a total market capitalization of 3.927 billion yuan [1] - The average PE ratio for the medical device industry is 55.76 times, with a median of 39.14 times, placing Kangdelai at the 39th position within the industry [1][2] Group 2 - Kangdelai's main business includes the research, production, sales, and service of medical devices such as puncture needles and infusion devices [1] - The company reported a revenue of 548 million yuan for Q1 2025, a year-on-year decrease of 3.82%, while net profit was 60.7042 million yuan, showing a slight increase of 0.28% [1] - The sales gross margin for the latest quarter was 32.02% [1]